| Year |
Citation |
Score |
| 2024 |
Girardi C, Duronio J, Patton R, O'Brien K, Clemens S, Brewer KL. A novel opioid/pramipexole combination treatment for the management of acute pain: a pilot study. Frontiers in Pain Research (Lausanne, Switzerland). 5: 1422298. PMID 39411383 DOI: 10.3389/fpain.2024.1422298 |
0.536 |
|
| 2021 |
Rodgers HM, Patton R, Yow J, Zeczycki TN, Kew K, Clemens S, Brewer KL. Morphine Resistance in Spinal Cord Injury-Related Neuropathic Pain in Rats is Associated With Alterations in Dopamine and Dopamine-Related Metabolomics. The Journal of Pain. PMID 34856409 DOI: 10.1016/j.jpain.2021.11.009 |
0.577 |
|
| 2020 |
Rodgers HM, Lim SA, Yow J, Dinkins ML, Patton R, Clemens S, Brewer KL. Dopamine D or D receptor modulators prevent morphine tolerance and reduce opioid withdrawal symptoms. Pharmacology, Biochemistry, and Behavior. 172935. PMID 32335101 DOI: 10.1016/J.Pbb.2020.172935 |
0.583 |
|
| 2019 |
Rodgers HM, Yow J, Evans E, Clemens S, Brewer KL. Dopamine D1 and D3 receptor modulators restore morphine analgesia and prevent opioid preference in a model of neuropathic pain. Neuroscience. PMID 30910641 DOI: 10.1016/J.Neuroscience.2019.03.034 |
0.61 |
|
| 2019 |
Lim S, Rodgers H, Jacob Y, Patton R, Clemens S, Brewer K. (283) Adjuvant Treatment with Dopamine Receptor Modulators Prevents the Development of Morphine Tolerance in a Rodent Model The Journal of Pain. 20: S45. DOI: 10.1016/J.Jpain.2019.01.205 |
0.583 |
|
| 2018 |
Meneely S, Dinkins ML, Kassai M, Lyu S, Liu Y, Lin CT, Brewer K, Li Y, Clemens S. Differential Dopamine D1 and D3 Receptor Modulation and Expression in the Spinal Cord of Two Mouse Models of Restless Legs Syndrome. Frontiers in Behavioral Neuroscience. 12: 199. PMID 30233336 DOI: 10.3389/Fnbeh.2018.00199 |
0.589 |
|
| 2017 |
Samir S, Yllanes AP, Lallemand P, Brewer KL, Clemens S. Morphine responsiveness to thermal pain stimuli is aging-associated and mediated by dopamine D1 and D3 receptor interactions. Neuroscience. PMID 28257894 DOI: 10.1016/J.Neuroscience.2017.02.042 |
0.569 |
|
| 2015 |
Bareiss SK, Dugan E, Brewer KL. PI3K mediated activation of GSK-3β reduces at-level primary afferent growth responses associated with excitotoxic spinal cord injury dysesthesias. Molecular Pain. 11: 35. PMID 26093674 DOI: 10.1186/S12990-015-0041-2 |
0.325 |
|
| 2014 |
Brewer KL, Baran CA, Whitfield BR, Jensen AM, Clemens S. Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord. Frontiers in Neural Circuits. 8: 62. PMID 24966815 DOI: 10.3389/Fncir.2014.00062 |
0.598 |
|
| 2013 |
Bareiss SK, Gwaltney M, Hernandez K, Lee T, Brewer KL. Excitotoxic spinal cord injury induced dysesthesias are associated with enhanced intrinsic growth of sensory neurons. Neuroscience Letters. 542: 113-7. PMID 23500027 DOI: 10.1016/J.Neulet.2013.03.008 |
0.358 |
|
| 2012 |
Keeler BE, Baran CA, Brewer KL, Clemens S. Increased excitability of spinal pain reflexes and altered frequency-dependent modulation in the dopamine D3-receptor knockout mouse. Experimental Neurology. 238: 273-83. PMID 22995602 DOI: 10.1016/J.Expneurol.2012.09.002 |
0.579 |
|
| 2009 |
Glazova M, Pak ES, Moretto J, Hollis S, Brewer KL, Murashov AK. Pre-differentiated embryonic stem cells promote neuronal regeneration by cross-coupling of BDNF and IL-6 signaling pathways in the host tissue. Journal of Neurotrauma. 26: 1029-42. PMID 19138107 DOI: 10.1089/Neu.2008.0785 |
0.304 |
|
| 2008 |
Brewer KL, Lee JW, Downs H, Oaklander AL, Yezierski RP. Dermatomal scratching after intramedullary quisqualate injection: correlation with cutaneous denervation. The Journal of Pain : Official Journal of the American Pain Society. 9: 999-1005. PMID 18619906 DOI: 10.1016/J.Jpain.2008.05.010 |
0.365 |
|
| 2007 |
Brewer K, Friesland A, Whitfield B, Nolan T. Neuroprotective Effects of Ceftriaxone Following Excitotoxic Spinal Cord Injury Academic Emergency Medicine. 14: S174-S174. DOI: 10.1197/J.Aem.2007.03.1201 |
0.338 |
|
| 2006 |
Hendricks WA, Pak ES, Owensby JP, Menta KJ, Glazova M, Moretto J, Hollis S, Brewer KL, Murashov AK. Predifferentiated embryonic stem cells prevent chronic pain behaviors and restore sensory function following spinal cord injury in mice. Molecular Medicine (Cambridge, Mass.). 12: 34-46. PMID 16838066 DOI: 10.2119/2006-00014.Hendricks |
0.353 |
|
| 2005 |
Nolan T, Brewer K. Spinal and supraspinal expression of PKC isoforms following excitotoxic spinal cord injury and implications for chronic pain management The Journal of Pain. 6: S10. DOI: 10.1016/J.Jpain.2005.01.037 |
0.358 |
|
| 2004 |
Abraham KE, McMillen D, Brewer KL. The effects of endogenous interleukin-10 on gray matter damage and the development of pain behaviors following excitotoxic spinal cord injury in the mouse. Neuroscience. 124: 945-52. PMID 15026134 DOI: 10.1016/J.Neuroscience.2004.01.004 |
0.334 |
|
| 2004 |
Brewer KL, Hardin JS. Neuroprotective effects of nicotinamide after experimental spinal cord injury. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 11: 125-30. PMID 14759952 DOI: 10.1111/J.1553-2712.2004.Tb01421.X |
0.363 |
|
| 2004 |
German B, Hack J, Brewer K, Meggs W. Efficacy of a Pressure-Immobilization bandage in delaying the onset of systemic toxicity in a porcine model of eastern coral snake (Micrurus fulvius) envenomation Annals of Emergency Medicine. 44: S90. DOI: 10.1016/J.Annemergmed.2004.07.293 |
0.316 |
|
| 2003 |
Brewer KL, McMillan D, Nolan T, Shum K. Cortical changes in cholecystokinin mRNA are related to spontaneous pain behaviors following excitotoxic spinal cord injury in the rat. Brain Research. Molecular Brain Research. 118: 171-4. PMID 14559369 DOI: 10.1016/J.Molbrainres.2003.08.006 |
0.374 |
|
| 2003 |
Meredith JT, Wait S, Brewer KL. A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine. The American Journal of Emergency Medicine. 21: 173-5. PMID 12811706 DOI: 10.1016/S0735-6757(02)42256-5 |
0.33 |
|
| 2001 |
Abraham KE, McGinty JF, Brewer KL. The role of kainic acid/AMPA and metabotropic glutamate receptors in the regulation of opioid mRNA expression and the onset of pain-related behavior following excitotoxic spinal cord injury. Neuroscience. 104: 863-74. PMID 11440816 DOI: 10.1016/S0306-4522(01)00134-8 |
0.37 |
|
| 2001 |
Abraham KE, Brewer KL. Expression of c-fos mRNA is increased and related to dynorphin mRNA expression following excitotoxic spinal cord injury in the rat. Neuroscience Letters. 307: 187-91. PMID 11438395 DOI: 10.1016/S0304-3940(01)01955-3 |
0.366 |
|
| 2001 |
Abraham KE, McGinty JF, Brewer KL. Spinal and supraspinal changes in opioid mRNA expression are related to the onset of pain behaviors following excitotoxic spinal cord injury. Pain. 90: 181-90. PMID 11166985 DOI: 10.1016/S0304-3959(00)00402-4 |
0.41 |
|
| 2000 |
Fairbanks CA, Schreiber KL, Brewer KL, Yu CG, Stone LS, Kitto KF, Nguyen HO, Grocholski BM, Shoeman DW, Kehl LJ, Regunathan S, Reis DJ, Yezierski RP, Wilcox GL. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proceedings of the National Academy of Sciences of the United States of America. 97: 10584-9. PMID 10984543 DOI: 10.1073/Pnas.97.19.10584 |
0.389 |
|
| 2000 |
Abraham KE, Brewer KL, McGinty JF. Opioid peptide messenger RNA expression is increased at spinal and supraspinal levels following excitotoxic spinal cord injury. Neuroscience. 99: 189-97. PMID 10924963 DOI: 10.1016/S0306-4522(00)00150-0 |
0.378 |
|
| 2000 |
Morrow TJ, Paulson PE, Brewer KL, Yezierski RP, Casey KL. Chronic, selective forebrain responses to excitotoxic dorsal horn injury. Experimental Neurology. 161: 220-6. PMID 10683288 DOI: 10.1006/Exnr.1999.7246 |
0.354 |
|
| 1999 |
Brewer KL, Bethea JR, Yezierski RP. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury. Experimental Neurology. 159: 484-93. PMID 10506519 DOI: 10.1006/Exnr.1999.7173 |
0.314 |
|
| Show low-probability matches. |